We are pleased to announce that Imagensys is finalizing the development of the Directional Gamma Probe, an innovative tool that promises to transform the process of sentinel lymph node localization in the operating room, a crucial step in radioguided surgery techniques.

This advanced device is the first in the world to feature three integrated sensors, enabling the precise identification of the exact direction in which the surgeon should orient the gamma probe. Thanks to this cutting-edge technology, the Directional Gamma Probe allows for rapid and accurate localization of the invaded lymph node, significantly reducing the duration of the procedure and improving the accuracy of intraoperative diagnosis.

The main advantages offered by the Directional Gamma Probe include:

Speed and precision: the device automatically guides the surgeon to the optimal direction for locating the sentinel lymph node, reducing the risk of errors and improving procedure times.

Better clinical outcomes: thanks to the faster identification, more targeted interventions can be performed, optimizing treatment and reducing the risk of tumor recurrence.

Unique innovation: with its multi-sensor system, the Directional Gamma Probe represents a breakthrough in oncology surgery technology, providing a significant improvement over traditional tools.

Currently, Imagensys is completing the final steps of the device’s validation and production process. Soon, the Directional Gamma Probe will be available on the market, ready to make a difference in operating rooms worldwide.

We are proud to be at the forefront of research and development in surgical technologies that not only improve the effectiveness of procedures but also contribute to patient well-being by reducing the risk of complications and optimizing post-operative outcomes.